For citations:
Tashireva L.A., Popova N.O., Alifanov V.V., Goldberg V.E., Kovalenko E.I., Artamonova E.V., Manikhas A.G., Ponomarenko D.M., Levchenko N.V., Rossokha E.I., Krasilnikova S.Yu., Zafirova M.A., Perelmuter V.M. Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study. Tumors of female reproductive system. 2021;17(4):48-55. (In Russ.) https://doi.org/10.17650/1994-4098-2021-17-4-48-55
Email this article 